Abstract
Impact of SGLT2 Inhibitor Therapy, EMPAgliflozin on RIGHT Ventricular Function in Patients with Right Heart Failure and Severe Pulmonary Hypertension in Chronic Pulmonary Disorders (EMPA-RIGHT Study)
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
